Biotech Startups

Fyodor Biosciences develops innovative diagnostics, medicines, and healthcare solutions with a focus on accessible global health. The company is led by scientists and health leaders with expertise in biomedical research and biotechnology.

1 investor

FYR develops a platform to analyze extracellular vesicles from blood samples and generate multiomics insights for disease understanding and personalized treatment selection. The company serves biomedical researchers, drug developers, and clinical diagnostics organizations.

1 investor

Fyteko is an agricultural technology company focused on sustainability in farming.

1 investor

Fziomed develops proprietary dual-polymer gel technology for use across multiple surgical applications. The company focuses on providing innovative solutions for surgical procedures.

1 investor

Gabar (Gabarx) is a biopharmaceutical company developing small-molecule drug candidates for central nervous system disorders such as anxiety and depression, drawing on deuterium-modified molecule chemistry. Its work spans clinical development, regulatory strategy, and CMC/quality across multiple therapeutic indications.

1 investor

Gaia Life is developing whole ovary banking aimed at preserving women's natural fertility and hormone balance, with the goal of extending reproductive years, health, and vitality. The company operates in the women's reproductive health and fertility space.

1 investor

Galam is a global company that develops and produces raw materials, flavors, and food additives for food and beverage manufacturers, pet food producers, and industrial applications. Operating through two divisions—one focused on innovative food technology solutions including sugar reduction and fiber enrichment, and another producing starches, syrups, and specialty ingredients—the company serves thousands of customers across over 60 countries.

1 investor

GalChimia is a European chemical synthesis contract research organization offering discovery chemistry, process chemistry, analytical services, and custom synthesis of complex molecules for pharmaceutical and biotech R&D partners. It works under fee-for-service and full-time-equivalent models and participates in R&D projects in areas such as antimicrobial resistance and oncology.

1 investor

Galdieria is a microalga species that produces a precious metal adsorbent material derived from its dried cells, designed for metal recovery in recycling and artisanal gold mining operations. The company manufactures and refines these biosorbent materials to extract precious metals from dilute solutions and mineral ores while enabling safer, toxin-free processing in small-scale mining contexts.

1 investor

Galen builds causal, computational models of living cells ("virtual cells") that aim to predict how a cell changes under a given intervention before experiments are run. Its initial focus is durability and exhaustion in engineered T cell therapies, serving scientists and drug developers working on cell therapies.

1 investor

Galenica distributes Leica confocal microscopes for biomedical research, enabling high-precision imaging of subcellular structures and dynamic cellular processes at nanoscopic resolution.

1 investor

Galenvs is a contract research organization offering design, development, testing, and bio-manufacturing services for healthcare and industrial customers. The company applies multidisciplinary technologies and data-driven approaches to enzyme engineering, carbon capture, and therapeutic development.

1 investor

Inventum Biotech develops software solutions for analytical, multimodal, and AI-based applications focused on preventing and managing non-communicable diseases using data and analytics.

1 investor

Gallant develops regenerative medicine for pets using allogeneic mesenchymal stromal cell (MSC) therapies, with a pipeline targeting conditions such as feline chronic gingivostomatitis, feline and canine osteoarthritis, feline chronic kidney disease, and canine atopic dermatitis. Its ready-to-use, intravenously administered therapies follow the FDA approval process and are offered to veterinarians and pet families across the U.S.

1 investor

Galvanize Therapeutics develops surgical ablation technology using its proprietary Aliya Pulsed Electric Field (PEF) energy to destroy soft tissue cells through regulated cell death mechanisms. Its products serve clinical fields such as interventional pulmonology and thoracic surgery.

1 investor

Galventa develops delivery technologies for food supplements and over-the-counter products designed to optimize dosage timing and bioavailability. The company focuses on improving the efficacy of nutraceutical formulations through galenic innovation.

1 investor

Gamida Cell develops cell therapy treatments designed to expand and enhance cells for therapeutic applications. The company focuses on delivering potentially curative therapies to patients with unmet medical needs.

1 investor

Gamma Diagnostics develops diagnostic tests based on Gamma Prime Fibrinogen (GPF), a blood biomarker for assessing inflammation and predicting cardiovascular and infectious disease outcomes. The company serves clinicians and healthcare providers seeking improved patient risk stratification and treatment planning.

1 investor

GammaTile is an FDA-cleared, bioresorbable collagen tile embedded with radiation sources that is implanted during brain tumor removal surgery to deliver targeted radiation to remaining cancer cells. It is indicated for patients with operable, newly diagnosed and recurrent brain tumors such as glioblastoma, brain metastases, and meningiomas.

1 investor

Gamow Labs builds an AI system that interprets whole genomes and clinical phenotypes to identify causative variants and produce ACMG-style clinical reports with auditable evidence and treatment recommendations. It serves clinical genetics workflows, focusing on genome interpretation and diagnosis of rare/hard cases.

1 investor

Gan & Lee appears to be a company with significant revenue (4.052 billion reported) and R&D investment activity (1.341 billion CNY), but the page visited does not contain clear information about its core business operations, products, or market focus.

1 investor

Gannet BioChem operates FDA-inspected cGMP manufacturing facilities in Alabama for polymer reagents, activated PEG compounds, and bulk pharmaceutical chemicals, serving research, clinical, and commercial programs at scales from grams to commercial volumes.

1 investor

1 investor

Gate2Brain develops therapeutics designed to cross biological barriers, particularly the blood-brain barrier, using a proprietary peptide-based technology platform. The company focuses on biotech drug development for conditions requiring brain delivery.

1 investor